Beyond COBRA: What Can Employers Offer?
Q&A with Brand Newland, CEO and co-founder of Goldfinch Health
We anticipate an increase in fee schedules even if demand doesn’t come back right away, and insurers are anticipating that. Providers are going to reprice accordingly.
The Search for Low-Cost, High-Quality Providers
Test, Test, and Test Again
Q&A with Ge Bai, Associate Professor of Accounting at Johns Hopkins Carey Business School and Johns Hopkins Bloomberg School of Public Health
Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
Good PT Is Great Rx
Q&A with Mary O’Donoghue, Chief Clinical and Product Officer, MedRisk
PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on Health
Show More in Vital Signs